CYTK
Cytokinetics, Incorporated
NASDAQ · Healthcare · Biotechnology · US
$72.72
−1.66%Margins
Gross margin
85.0%
EBITDA margin
-1153.6%
EBIT margin
-993.0%
Net margin
-1259.9%
FCF margin
-818.4%
515.3%
Return on equity
-46.5%
Return on assets
-64.2%
Return on invested capital
0.04x
Asset turnover
-$555.5M
Cash from operations
$8.38
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026